Education
About Us
Working with TipRanks
Follow Us
Psyrx Bio-Tech (IL:PSRX)
:PSRX
Total Valuation
Psyrx Bio-Tech has a market cap or net worth of ₪12.41M. The enterprise value is -44.83K.
Market Cap₪12.41M
Enterprise Value-44.83K
Share Statistics
Psyrx Bio-Tech has 10,226,146 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding10,226,146
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Psyrx Bio-Tech’s return on equity (ROE) is 1.28 and return on invested capital (ROIC) is 164.63%.
Return on Equity (ROE)1.28
Return on Assets (ROA)-12.20
Return on Invested Capital (ROIC)164.63%
Return on Capital Employed (ROCE)1.65
Revenue Per Employee-5.08K
Profits Per Employee-386.75K
Employee Count6
Asset Turnover-0.16
Inventory Turnover8.56
Valuation Ratios
The current PE Ratio of Psyrx Bio-Tech is 0.2. Psyrx Bio-Tech’s PEG ratio is 0.00059.
PE Ratio0.2
PS Ratio-2.81
PB Ratio-0.05
Price to Fair Value-0.05
Price to FCF-0.06
Price to Operating Cash Flow-0.47
PEG Ratio0.00059
Income Statement
In the last 12 months, Psyrx Bio-Tech had revenue of -30.46K and earned -2.32M in profits. Earnings per share was -7.98.
Revenue-30.46K
Gross Profit-882.90K
Operating Income-2.46M
Pretax Income-2.32M
Net Income-2.32M
EBITDA―
Earnings Per Share (EPS)-7.98
Cash Flow
In the last 12 months, operating cash flow was -1.17M and capital expenditures 683.01K, giving a free cash flow of -486.60K billion.
Operating Cash Flow-1.17M
Free Cash Flow-486.60K
Free Cash Flow per Share-0.05
Dividends & Yields
Psyrx Bio-Tech pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-0.63
52-Week Price Change-77.10%
50-Day Moving Average―
200-Day Moving Average―
Relative Strength Index (RSI)―
Average Volume (3m)139.30K
Important Dates
Psyrx Bio-Tech upcoming earnings date is ―, ―.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
Psyrx Bio-Tech as a current ratio of 0.11, with Debt / Equity ratio of 0.00%
Current Ratio0.11
Quick Ratio0.05
Debt to Market Cap0.00
Net Debt to EBITDA<0.01
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Psyrx Bio-Tech has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Psyrx Bio-Tech EV to EBITDA ratio is -0.03, with an EV/FCF ratio of -0.04.
EV to Sales-2.08
EV to EBITDA-0.03
EV to Free Cash Flow-0.04
EV to Operating Cash Flow-0.04
Balance Sheet
Psyrx Bio-Tech has ₪203.69K in cash and marketable securities with ₪0.00 in debt, giving a net cash position of ₪203.69K billion.
Cash & Marketable Securities₪203.69K
Total Debt₪0.00
Net Cash₪203.69K
Net Cash Per Share₪0.02
Tangible Book Value Per Share-₪5.14
Margins
Gross margin is -610.23%, with operating margin of 8080.43%, and net profit margin of 7617.35%.
Gross Margin-610.23%
Operating Margin8080.43%
Pretax Margin7617.35%
Net Profit Margin7617.35%
EBITDA Margin7326.35%
EBIT Margin8080.43%
Analyst Forecast
The average price target for Psyrx Bio-Tech is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―